PARP16 and cardiac hypertrophy: [152] demonstrated that PARP16 binds to IRE1α and facilitates its ADP‐ribosylation, which mechanistically activates the IRE1α–X‐box binding protein 1–GATA4 axis to drive pathological cardiac hypertrophy.